股本结构
单位：万股
| 公告日期 | 2024-04-02 | 2023-12-26 | 2023-12-21 | 2023-12-15 | 2023-11-15 | 2023-05-15 |
|---|---|---|---|---|---|---|
| 证券总股本 | 4042.96 | 3937.68 | 3937.68 | 3937.68 | 3935.89 | 3904.07 |
| 普通股本 | 4042.96 | 3937.68 | 3937.68 | 3937.68 | 3935.89 | 3904.07 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-28 | 2023-12-26 | 2023-12-21 | 2023-12-04 | 2023-09-30 | 2023-05-15 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-04-02 | 4042.96 | 未披露 | 定期报告 | 2024-03-28 |
| 2023-12-26 | 3937.68 | 未披露 | 定期报告 | 2023-12-26 |
| 2023-12-21 | 3937.68 | 未披露 | 定期报告 | 2023-12-21 |
| 2023-12-15 | 3937.68 | 未披露 | 定期报告 | 2023-12-04 |
| 2023-11-15 | 3935.89 | 未披露 | 定期报告 | 2023-09-30 |
| 2023-05-15 | 3904.07 | 未披露 | 定期报告 | 2023-05-15 |
| 2023-05-15 | 3902.87 | 未披露 | 定期报告 | 2023-03-31 |
| 2023-03-31 | 4064.38 | 未披露 | 定期报告 | 2023-03-30 |
| 2023-03-31 | 3850.43 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Share repurchase
Share-based payments
Share cancellation
Warrants expired
PSUs converted to shares
|
2022-12-31 |
| 2022-11-14 | 3810.43 | 未披露 | 定期报告 | 2022-11-11 |
| 2022-11-14 | 3811.43 | 未披露 |
更多>>
From December 31, 2021 to September 30, 2022
Share repurchase
Shares-based payments
Share cancellation
|
2022-09-30 |
| 2022-08-12 | 3821.82 | 未披露 | 定期报告 | 2022-08-12 |
| 2022-08-12 | 3840.72 | 未披露 |
更多>>
From December 31, 2021 to June 30, 2022
Share repurchase
Shares-based payments
Share cancellation
|
2022-06-30 |
| 2022-05-23 | 3852.52 | 未披露 | 定期报告 | 2022-05-19 |
| 2022-05-13 | 3850.48 | 未披露 | 定期报告 | 2022-05-13 |
| 2022-03-31 | 4045.08 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
|
2021-12-31 |
| 2021-11-15 | 4042.40 | 未披露 | 定期报告 | 2021-11-12 |
| 2021-11-15 | 4041.06 | 未披露 |
更多>>
From December 31, 2020 to September 30, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
|
2021-09-30 |
| 2021-09-21 | 4055.79 | 未披露 | 定期报告 | 2021-09-13 |
| 2021-08-13 | 3583.56 | 未披露 |
更多>>
From December 31, 2020 to June 30, 2021
Shares issued
Share-based payments
Share cancellation
|
2021-06-30 |
| 2021-05-07 | 3599.19 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Shares issued
Share-based payments
|
2021-03-31 |
| 2021-03-17 | 3511.51 | 未披露 | 定期报告 | 2021-03-16 |
| 2021-02-11 | 2651.80 | 未披露 | 定期报告 | 2021-02-10 |
| 2021-01-27 | 1916.17 | 未披露 | 定期报告 | 2021-01-26 |
| 2021-03-17 | 1916.17 | 未披露 |
更多>>
From December 31, 2019 to December 31, 2020
Shares issued
Share-based payments
Share options exercised
|
2020-12-31 |
| 2020-11-16 | 1484.35 | 未披露 |
更多>>
from December 31, 2019 to September 30, 2020
Shares issued
Share-based payments
Share options exercised
|
2020-09-30 |
| 2020-08-11 | 1021.98 | 未披露 |
更多>>
from December 31, 2019 to June 30, 2020
Shares issued
Share-based payments
Share options exercised
|
2020-06-30 |
| 2020-07-13 | 1019.75 | 未披露 |
更多>>
The Corporation announced that it entered into definitive agreements with certain institutional investors pertaining to the private placement (the "Private Placement") by certain placement agents led by A.G.P./Alliance Global Partners (collectively, the "Placement Agents") of an aggregate of 1,500,000 Class B Shares at a price of C$6.75 per Class B Share. The Private Placement was completed on June 8, 2020.
|
2020-06-08 |
| 2020-05-15 | 869.75 | 未披露 | 定期报告 | 2020-05-14 |
| 2020-05-15 | 863.37 | 未披露 |
更多>>
from December 31, 2019 to March 31, 2020
Shares issued
Share-based payments
|
2020-03-31 |
| 2020-03-04 | 815.88 | 未披露 | 定期报告 | 2020-03-03 |
| 2020-03-04 | 790.58 | 未披露 |
更多>>
from December 31, 2018 to January 9, 2020
Shares issued
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.
Share options exercised
Warrants exercised
|
2020-01-09 |
From December 31, 2021 to December 31, 2022
Share repurchase
Share-based payments
Share cancellation
Warrants expired
PSUs converted to shares
From December 31, 2021 to September 30, 2022
Share repurchase
Shares-based payments
Share cancellation
From December 31, 2021 to June 30, 2022
Share repurchase
Shares-based payments
Share cancellation
From December 31, 2020 to December 31, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
From December 31, 2020 to September 30, 2021
Shares issued
Share-based payments
Share cancelation
Lucid acquisition
From December 31, 2020 to June 30, 2021
Shares issued
Share-based payments
Share cancellation
From December 31, 2020 to March 31, 2021
Shares issued
Share-based payments
From December 31, 2019 to December 31, 2020
Shares issued
Share-based payments
Share options exercised
from December 31, 2019 to September 30, 2020
Shares issued
Share-based payments
Share options exercised
from December 31, 2019 to June 30, 2020
Shares issued
Share-based payments
Share options exercised
The Corporation announced that it entered into definitive agreements with certain institutional investors pertaining to the private placement (the "Private Placement") by certain placement agents led by A.G.P./Alliance Global Partners (collectively, the "Placement Agents") of an aggregate of 1,500,000 Class B Shares at a price of C$6.75 per Class B Share. The Private Placement was completed on June 8, 2020.
from December 31, 2019 to March 31, 2020
Shares issued
Share-based payments
from December 31, 2018 to January 9, 2020
Shares issued
Issued on acquisition of net assets of Prismic Pharmaceuticals, Inc.
Share options exercised
Warrants exercised